SLXP: Salix Pharmaceuticals, Ltd. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
2001	11.25	20.25	9.00	80.00%
2002	20.25	6.99	-13.26	-65.48%
2003	6.99	22.68	15.69	224.46%
2004	22.68	26.385*	3.705	16.34%
2005	17.59	17.58	-0.01	-0.06%
2006	17.58	12.17	-5.41	-30.77%
2007	12.17	7.88	-4.29	-35.25%
2008	7.88	8.83	0.95	12.06%
2009	8.83	25.39	16.56	187.54%
2010	25.39	46.96	21.57	84.95%
2011	46.96	47.85	0.89	1.90%
2012	47.85	40.47	-7.38	-15.42%
2013	40.47	89.94	49.47	122.24%
2014	89.94	114.94	25.00	27.80%
2015	114.94	173.00*	58.06	50.51%

*The 2004 ending price for Salix Pharmaceuticals has been adjusted for 3 for 2 stock split.
*In 2015, Valeant Pharmaceuticals (VRX) completed its acquisition of Salix Pharmaceuticals (SLXP) for $173 per share.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).